The company, founded by a team of experts in DNA sequencing and diagnostic analyses in oncology, combines advanced testing of cancer biomarkers with a proprietary treatment knowledge database to provide physicians with better treatment decisions for cancer patients. OncoDNA also supports research and drug development in cancer and genetic diseases, offering a unique portfolio that includes NGS services, biomarker testing, data interpretation software, and clinical decision support tools. With over 100 employees across 9 countries and collaborations with accredited laboratories worldwide, OncoDNA is committed to delivering the promise of precision medicine.